Real Brands, Inc. (RLBD) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.93: the stock has moved about 7% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerReal Brands, Inc. (RLBD) trades at $0.0001. Real Brands, Inc. specializes in the extraction and wholesale of hemp-derived CBD products, including oils and topical applications. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for RLBD: RLBD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Real Brands, Inc. (RLBD) Healthcare & Pipeline Overview
Real Brands, Inc. is a healthcare company focused on the extraction and wholesale of hemp-derived CBD products, positioning itself in a rapidly expanding market with a diverse product range including oils, creams, and capsules.
What Is the Investment Thesis for RLBD?
Real Brands, Inc. is positioned in the rapidly growing CBD market, which is projected to reach $13.4 billion by 2028, growing at a CAGR of 21.2%. The company’s diverse product line, including topical creams, oils, and capsules, provides multiple revenue streams. However, the current financial metrics indicate challenges, including a profit margin of -2203.4% and a gross margin of -41.6%, highlighting the need for operational improvements. The company’s focus on quality extraction processes and compliance with regulatory standards could serve as a competitive advantage in a fragmented market. Investors may want to evaluate the potential for growth against the backdrop of ongoing financial challenges.
Based on FMP financials and quantitative analysis
RLBD Key Highlights
Market Cap: $0.00B, indicating a current lack of market valuation.
- P/E Ratio: -0.02, suggesting negative earnings.
- Profit Margin: -2203.4%, highlighting significant operational losses.
- Gross Margin: -41.6%, reflecting challenges in cost management.
- Beta: 0.93, indicating lower volatility compared to the market.
Who Are RLBD's Competitors?
RLBD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SXTC China SXT Pharmaceuticals, Inc. | $2.59 | -8.48% | — | |
| YCBD cbdMD, Inc. | $0.38 | +1.42% | $5.10M | — |
| AKAN Akanda Corp. | $3.43 | -14.89% | $9.05M | — |
| QNTM Quantum BioPharma Ltd. | $1.42 | -6.58% | $9.13M | 30 5-pillar |
| BFRI Biofrontera Inc. | $0.60 | +1.10% | $10.8M | — |
| COSM COSM | $2.87 | -2.71% | $14.4M | — |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | $3.90 | +2.01% | $18.6M | 32 5-pillar |
| TXMD TherapeuticsMD, Inc. | $1.81 | -5.24% | $21.0M | 34 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RLBD's Key Strengths?
Established presence in the growing CBD market.
- Diverse product offerings catering to various consumer segments.
- Expertise in extraction and product formulation.
What Are RLBD's Weaknesses?
Limited workforce, currently employing only one individual.
- Negative profit margins indicating operational challenges.
- Lack of market cap suggests low investor confidence.
What Are the Key Risks for RLBD?
Financial-distress signal — its Altman Z-Score of -20.62 sits in the distress zone (elevated bankruptcy risk).
- Regulatory changes that could impact product sales.
- Intense competition from established CBD brands.
- Financial instability due to negative profit margins.
- Shifts in consumer preferences away from CBD products.
What Threats Does RLBD Face?
- Intense competition from other CBD producers.
- Regulatory changes that could impact operations.
- Market volatility and shifting consumer preferences.
What Are RLBD's Competitive Advantages?
- Expertise in CBD extraction and product formulation.
- Commitment to quality and compliance with industry regulations.
- Diverse product range catering to various consumer needs.
- Established relationships with suppliers and distributors.
What Does RLBD Do?
Founded in 2011 and headquartered in North Providence, Rhode Island, Real Brands, Inc. engages in the extraction of hemp cannabinol (CBD) oil and isolate. The company operates primarily in the wholesale market, providing a variety of hemp-derived CBD products that cater to diverse consumer needs. Its product offerings include topical creams and gels, cosmetics, tinctures, oils, capsules, vape cartridges, oral sprays, lotions, and other innovative products. Over the years, Real Brands has established itself in the CBD market, which has been experiencing significant growth due to increasing consumer interest in wellness products derived from hemp. The company's commitment to quality and compliance with industry standards positions it as a reliable supplier in the evolving landscape of CBD products. With a small team of just one employee, Real Brands focuses on streamlining operations to maximize efficiency and responsiveness to market demands. As the CBD market continues to expand, Real Brands aims to leverage its expertise in product development and distribution to capture a larger share of this burgeoning industry.
What Products and Services Does RLBD Offer?
- Extracts hemp cannabinol (CBD) oil and isolate.
- Wholesale CBD oils and isolates to various markets.
- Produces and sells a range of hemp-derived CBD products.
- Offers topical creams, gels, and cosmetics infused with CBD.
- Provides tinctures, oils, capsules, and vape cartridges.
- Develops oral sprays and lotions for consumer use.
How Does RLBD Make Money?
- Real Brands generates revenue through the wholesale of CBD oils and isolates.
- The company sells a variety of hemp-derived products directly to consumers and retailers.
- Focuses on product diversification to cater to different consumer preferences and needs.
- Utilizes a streamlined operational model to maintain cost efficiency and responsiveness.
What Industry Does RLBD Operate In?
The drug manufacturing industry, particularly in the specialty and generic sectors, is witnessing a significant shift towards natural and hemp-derived products. The CBD market is expanding rapidly, driven by increasing consumer awareness of health benefits and changing regulations. Real Brands, Inc. operates within this dynamic environment, competing with other companies such as CWWBF, FFNTF, GPFT, HMPQ, and LRSV. As the market size for CBD products is projected to grow substantially, companies that can effectively navigate regulatory landscapes and consumer preferences are likely to gain a competitive edge.
Who Are RLBD's Key Customers?
- Retailers looking to stock CBD products.
- Health-conscious consumers interested in natural wellness solutions.
- Online shoppers seeking convenience in purchasing CBD goods.
- Distributors looking for quality CBD products for resale.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Real Brands, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in North Providence, US. The company is led by CEO Thomas Kidrin. RLBD has traded publicly since 2000.
Key Financial Metrics
Return on equity for Real Brands, Inc. stands at 129.5%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -51.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Real Brands, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -20.62 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
8 transactions · 0 purchases, 0 sales, 8 other transactions · 6 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
RLBD Latest News
No recent news available for RLBD.
RLBD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RLBD.
Price Targets
Wall Street price target analysis for RLBD.
RLBD MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RLBD; grades run from A+ (80-100) to F (below 30).
Leadership: Thomas Kidrin
CEO
Thomas Kidrin has been at the helm of Real Brands, Inc. since its inception in 2011. With a background in business management, he has guided the company through the challenges of the evolving CBD market. His leadership focuses on operational efficiency and product quality, ensuring that Real Brands remains competitive in a rapidly changing industry.
Track Record: Under Kidrin's leadership, Real Brands has developed a diverse product line and established a presence in the CBD market. His strategic decisions have aimed at enhancing product quality and compliance with industry standards, positioning the company for future growth.
RLBD OTC Market Information
The OTC Other tier represents companies that do not meet the requirements for higher tiers like NYSE or NASDAQ. Companies in this tier may have less stringent reporting requirements, leading to potentially lower transparency for investors.
- OTC Tier: OTC Other
- Limited financial reporting and transparency compared to larger exchanges.
- Potential for lower liquidity and higher volatility in stock price.
- Regulatory risks associated with the cannabis and CBD industry.
- Verify the company's financial reports and disclosures.
- Assess the competitive landscape and market positioning.
- Evaluate the regulatory environment for CBD products.
- Investigate the company's operational efficiency and management.
- Review customer feedback and product quality.
- Established presence in the CBD market since 2011.
- Diverse product offerings indicating a commitment to innovation.
- Compliance with industry regulations and standards.
Common Questions About RLBD (Healthcare)
What are the main risks for RLBD?
Real Brands, Inc. faces several risks, including regulatory uncertainties that could impact its ability to market CBD products. Additionally, the company contends with intense competition in the CBD sector and ongoing financial challenges that may hinder its growth prospects.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Data provided for informational purposes only.
- Financial reporting is limited due to OTC classification; further verification is recommended.